Specific immunotherapy (IT) might be considered in patients with cross allergy in two types of clinical settings.
Therapeutic vaccines for food allergens might be substituted to oral desensitization and could be applied first to peanut allergy and to cross allergy between pollens and fruit or vegetable linked to panallergens.
Peanut-lupin cross allergy has been reported in which IgE antibodies that recognise peanut allergens also cross react with NLL conglutins [ 14, 15].
Type of alert was classified into one of nine mutually exclusive categories: drug disease contraindication, cumulative side effects, drug age contraindication, therapy duplication, drug interaction, excess dose, renal dose adjustment, drug or potential cross allergy and other.
Cephalexin and other first-generation cephalosporins are known to have a modest cross-allergy in patients with penicillin hypersensitivity [11, 12, 13, 14, 15, 19].
Palladium-gold is a more expensive alloy than nickel-gold, but seldom causes allergic reactions (though certain cross-allergies with nickel may occur).
Currently, data are lacking about cross-allergy.
In cases of non-IgE-mediated allergy, cross-allergy is uncommon with cephalosporins and carbapenems, and never observed with fluoroquinolones, aminoglycosides, glycopeptides, imidazoles and linezolid.
These may be cross-allergies.
Its platform, now used by more than 55,000 doctors from all medical specialties in the country, helps cross-check for allergies and drug interactions, makes treatment adherence easier and improves health outcomes.
